Logo image of IX

ORIX - SPONSORED ADR (IX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IX - US6863301015 - ADR

29.425 USD
-0.15 (-0.52%)
Last: 12/30/2025, 10:38:36 AM
Fundamental Rating

4

Taking everything into account, IX scores 4 out of 10 in our fundamental rating. IX was compared to 98 industry peers in the Financial Services industry. IX has a medium profitability rating, but doesn't score so well on its financial health evaluation. IX is valued correctly, but it does not seem to be growing. Finally IX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IX was profitable.
IX had a positive operating cash flow in the past year.
IX had positive earnings in each of the past 5 years.
Each year in the past 5 years IX had a positive operating cash flow.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

The Return On Assets of IX (2.08%) is better than 63.27% of its industry peers.
IX has a Return On Equity (8.60%) which is comparable to the rest of the industry.
IX's Return On Invested Capital of 2.59% is in line compared to the rest of the industry. IX outperforms 48.98% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IX is significantly below the industry average of 8.44%.
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROIC 2.59%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

IX has a Profit Margin of 12.23%. This is comparable to the rest of the industry: IX outperforms 57.14% of its industry peers.
IX's Profit Margin has declined in the last couple of years.
The Operating Margin of IX (19.00%) is better than 66.33% of its industry peers.
In the last couple of years the Operating Margin of IX has remained more or less at the same level.
IX has a Gross Margin of 42.41%. This is in the better half of the industry: IX outperforms 63.27% of its industry peers.
In the last couple of years the Gross Margin of IX has grown nicely.
Industry RankSector Rank
OM 19%
PM (TTM) 12.23%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

IX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IX has been reduced compared to 5 years ago.
IX has a better debt/assets ratio than last year.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

IX has an Altman-Z score of 0.79. This is a bad value and indicates that IX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IX (0.79) is comparable to the rest of the industry.
IX has a Debt/Equity ratio of 1.54. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.54, IX is doing worse than 62.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.7
WACC3.68%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

IX has a Current Ratio of 0.94. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
IX has a Current ratio (0.94) which is in line with its industry peers.
IX has a Quick Ratio of 0.94. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
IX has a Quick ratio of 0.83. This is comparable to the rest of the industry: IX outperforms 45.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.83
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

3

3. Growth

3.1 Past

The earnings per share for IX have decreased strongly by -10.80% in the last year.
The Earnings Per Share has been decreasing by -1.09% on average over the past years.
The Revenue has been growing slightly by 3.16% in the past year.
IX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.43% yearly.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%25.45%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%10.73%

3.2 Future

The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
Based on estimates for the next years, IX will show a small growth in Revenue. The Revenue will grow by 6.00% on average per year.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
EPS Next 5Y14.58%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y7.17%
Revenue Next 5Y6%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.75, the valuation of IX can be described as correct.
IX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.84, IX is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.16, which indicates a correct valuation of IX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IX is on the same level as its industry peers.
IX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.75
Fwd PE 13.16
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IX indicates a somewhat cheap valuation: IX is cheaper than 66.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.12
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

IX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IX's earnings are expected to grow with 19.91% in the coming years.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y19.91%

7

5. Dividend

5.1 Amount

IX has a Yearly Dividend Yield of 3.36%.
Compared to an average industry Dividend Yield of 2.36, IX pays a bit more dividend than its industry peers.
IX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 3.36%

5.2 History

The dividend of IX is nicely growing with an annual growth rate of 7.63%!
IX has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of IX decreased in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

38.56% of the earnings are spent on dividend by IX. This is a low number and sustainable payout ratio.
IX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.56%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B -600B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

ORIX - SPONSORED ADR

NYSE:IX (12/30/2025, 10:38:36 AM)

29.425

-0.15 (-0.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-06 2025-11-06
Earnings (Next)02-09 2026-02-09
Inst Owners49.84%
Inst Owner Change1.21%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.77B
Revenue(TTM)2.94T
Net Income(TTM)351.60B
Analysts77.33
Price Target29.8 (1.27%)
Short Float %0.04%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 3.36%
Yearly Dividend0.77
Dividend Growth(5Y)7.63%
DP38.56%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-31 2025-03-31 (0.403487)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.62%
Min EPS beat(2)-26.43%
Max EPS beat(2)-6.82%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.83%
Min Revenue beat(2)-9.12%
Max Revenue beat(2)-8.55%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.97%
PT rev (3m)2.86%
EPS NQ rev (1m)0.59%
EPS NQ rev (3m)0.59%
EPS NY rev (1m)4.78%
EPS NY rev (3m)9.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)1.43%
Valuation
Industry RankSector Rank
PE 13.75
Fwd PE 13.16
P/S 1.78
P/FCF N/A
P/OCF 3.94
P/B 1.25
P/tB 1.74
EV/EBITDA 10.12
EPS(TTM)2.14
EY7.27%
EPS(NY)2.24
Fwd EY7.6%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)7.47
OCFY25.38%
SpS16.51
BVpS23.49
TBVpS16.9
PEG (NY)0.54
PEG (5Y)N/A
Graham Number33.63
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROCE 3.7%
ROIC 2.59%
ROICexc 2.83%
ROICexgc 3.72%
OM 19%
PM (TTM) 12.23%
GM 42.41%
FCFM N/A
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 6.65
Cap/Depr 339.82%
Cap/Sales 47.23%
Interest Coverage 250
Cash Conversion 137.5%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.83
Altman-Z 0.79
F-Score6
WACC3.68%
ROIC/WACC0.7
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%25.45%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y19.91%
EPS Next 5Y14.58%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%10.73%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y7.17%
Revenue Next 5Y6%
EBIT growth 1Y-4.51%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year12536.4%
EBIT Next 3Y450.78%
EBIT Next 5YN/A
FCF growth 1Y-235.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.57%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX FAQ

Can you provide the ChartMill fundamental rating for ORIX - SPONSORED ADR?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


What is the valuation status of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a valuation rating of 4 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


What is the profitability of IX stock?

ORIX - SPONSORED ADR (IX) has a profitability rating of 5 / 10.


What is the financial health of ORIX - SPONSORED ADR (IX) stock?

The financial health rating of ORIX - SPONSORED ADR (IX) is 2 / 10.


Can you provide the expected EPS growth for IX stock?

The Earnings per Share (EPS) of ORIX - SPONSORED ADR (IX) is expected to grow by 25.58% in the next year.